Heng Xu
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Topics
- Immunotherapy and Immune Responses (15 papers)Cancer Immunotherapy and Biomarkers (11 papers)RNA modifications and cancer (7 papers)
- Cited by
- Cancer ResearchHepatologyImmunology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Heng Xu
82 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 136
- Molecular Biology 894
- Cancer Research 440
- Oncology 338
- Immunology 277
- Pulmonary and Respiratory Medicine 214
Countries citing papers authored by Heng Xu
This map shows the geographic impact of Heng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng Xu more than expected).
Fields of papers citing papers by Heng Xu
This network shows the impact of papers produced by Heng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng Xu. The network helps show where Heng Xu may publish in the future.
Co-authorship network of co-authors of Heng Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Heng Xu. A scholar is included among the top collaborators of Heng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng Xu. Heng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 4 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 6 | |
| 6 | 7 | |
| 7 | 11 | |
| 8 | 0 | |
| 9 | 6 | |
| 10 | 31 | |
| 11 | 15 | |
| 12 | 16 | |
| 13 | 2 | |
| 14 | 10 | |
| 15 | 105 | |
| 16 | 118 | |
| 17 | 92 | |
| 18 | 26 | |
| 19 | 55 | |
| 20 | 28 |
About Heng Xu
Heng Xu is a scholar working on Immunology, Cancer Research and Oncology, having authored 86 papers that have together received 1.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (15 papers), Cancer Immunotherapy and Biomarkers (11 papers) and RNA modifications and cancer (7 papers). The work is most often cited by research in Cancer Research (440 citations), Hepatology (106 citations) and Immunology (277 citations). Heng Xu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yang Shu, Min Jiang, Yaomei Tian, Bailing Zhou, Shouyue Zhang, Zhenyu Ding, Liming Yu, Changying Guo, Lin Chen and Li Yang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.